132 - Ross O'Neill, PhD & Hubert Lim, PhD - Lenire: The First FDA-Approved Bimodal Tinnitus Treatment
Guests: Ross O'Neill Ph.D (Founding CEO) & Hubert Lim Ph.D (Chief Scientific Officer) of Neuromod
Dave is joined by Ross & Hubert to discuss:
- The backstory of how Ross & Hubert met and ultimately partnered together on Lenire
- Hubert's research and papers he wrote about paired stimulation & Pavlovian conditioning, which included data that identified tongue stimulation combined with sound as a promising direction to pursue
- An overview of what exactly tinnitus is and why Lenire presents such a novel approach to treating tinnitus
- Other types of synchronous-stimuli approaches that have emerged in other healthcare verticals (i.e. mirror therapy for phantom limb pain)
- The challenging process of gaining FDA approval and the clinical trials that were conducted throughout the process
- Being featured as the cover story on Nature Communications
- The initial roll-out of Lenire, the current state of the provider network, and the real-world data that's being collected and published
More episodes from "Future Ear Radio"
Don't miss an episode of “Future Ear Radio” and subscribe to it in the GetPodcast app.
